SRTA

$4.44+3.74%visit website

Strata Critical Medical, Inc.

Market Cap

$397M

Live price × SEC shares (Oct 26, 2026)

Sector

Health Care

Industry

Health Care

Beta (raw)

2.56

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Sep 2026 · negative earnings

P/S (TTM)

1.4

TTM to Sep 2026 · revenue

P/B

1.4

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	Q3 FY2026 Sep 30, 2026	TTM Sep 30, 2026
Revenue	66,787	67,384	72,506	74,081	280,758
Cost of revenue	52,375	53,267	57,291	57,261	220,194
Gross profit	14,412	14,117	15,215	16,820	60,564
Selling, general & administrative	19,341	15,605	13,996	15,140	64,082
Total operating expenses	20,817	17,091	20,623	20,651	79,182
Operating income	(6,405)	(2,974)	(5,408)	(3,831)	(18,618)
Pretax income	(5,388)	2,402	(10,516)	(7,615)	(21,117)
Income tax	0.00	0.00	0.00	0.00	0.00
Net income	(8,833)	2,154	(10,516)	(7,615)	(24,810)
EPS (basic) ($)		0.03	(0.12)	(0.09)	(0.30)
EPS (diluted) ($)		0.03	(0.12)	(0.09)	(0.30)
Weighted avg. shares (basic)		85,323	86,214	88,274
Weighted avg. shares (diluted)		90,169	86,214	88,274

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Nov 3, 2026, period ended Sep 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 24 more quarters, back to Q3 FY2019, with Tormere Pro.

Corporate Events (8-K)

1 filing in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Nov 3, 2026 accepted 8:11 AM ET	2.02Earnings release	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

51%

W/W +10.3pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Velocity Score

0.51x

Avg Daily Selling (90d)

56.6 sh/day

Baseline Daily Selling

266 sh/day

Unique Sellers (90d)

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-08-10	2026-08-13	Love Reginald	Director	Sale	5,091	$5.75	$29K	146.5K	View
2026-05-22	2026-05-26	Cohen Amir	Chief Accounting Officer	Sale	40.6K	$5.91	$240K	151.3K	View
2026-05-21	2026-05-26	Cohen Amir	Chief Accounting Officer	Sale	10.3K	$5.79	$60K	191.8K	View
2026-05-11	2026-05-13	Cohen Amir	Chief Accounting Officer	Sale	14.3K	$5.79	$83K	202.1K	View